Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Budgeting study

261 views

Published on

  • Be the first to comment

  • Be the first to like this

Budgeting study

  1. 1. BUDGETING THE INDUSTRY- SPONSORED CLINICAL RESEARCH STUDYCarolyn White, Manager, Study Coord & Conduct UnitCenter for the Advancement of Clinical Research (CACR) Heather Offhaus, Director Medical School Grants Office
  2. 2. Objective:To learn the fundamentals ofpreparing a clinical trial budget
  3. 3. Developing and Negotiating Successful Study Budgets• U-M research community provides important resources to help you – Departmental Mentoring – Department Res. Grants Admin. – Medical School Grants Office – DRDA Seminars• Successful budgeting is definitely an art refined by experience
  4. 4. Read the Protocol• Identify items that will generate expenses for the site – Number & complexity of subject visits – Estimated time required for study visits – Procedures to be performed – Difficulty of meeting Inclusion/Exclusion criteria – Staffing needs for duration of study
  5. 5. Determine Recruitment Potential• What is a reasonable and realistic accrual goal? – What measures are necessary to reach the desired subject population? – How many subjects must be screened to identify an eligible participant? – What is the recruitment time frame?
  6. 6. Clinical Budget Concepts:• Must cover all costs• Needs to be somewhat flexible• If not in budget, sponsor is not obligated to pay
  7. 7. Clinical Trial Budget Categories Fixed Competitive Site BudgetBudget Bid ProposalOffered by Site submits Site submits tosponsor or proposal to sponsor without CRO sponsor in site pre-determined selection process budget limits
  8. 8. Categorize Budget Items• Fixed and Up- • Costs Related Front Costs to Subject Visits – Are needed for – Sponsor study conduct and proposals usually incurred whether or link all budget not a subject is items directly to enrolled. patient visits.
  9. 9. DISCLAIMER!!!• We will talk through many types of charges• We will offer many ways of looking at things• BUT, this is not the exhaustive list! Many items are protocol specific with hundreds of possibilities!
  10. 10. Determine Universal Costs for Study Conduct• What institutional approvals are needed?• Are fees charged?• Determine institutional Indirect Cost rate
  11. 11. Plan for Study Start-Up Costs• Costs for preparation of informed consent document and applications• IRB Fee - $1800• GCRC Administrative Fee - $750• IDS Study Start-up Fee - $1150• Advertising**above fees charged whether or not patients are accrued
  12. 12. Indirect Cost Recovery (aka Facility & Administrative charges or Overhead)These are a real cost to the university• Determine correct rate to use on your study• Call Me!!! Contact: MSA Grants Office, Heather Offhaus 763-4272.
  13. 13. Salary Support for the Research Team• Investigator• Co-Investigators• Study Coordinator• Office Personnel• Technical Support• Laboratory Staff• Professional/Consultant Fees** Don’t forget Fringe Benefits for each!
  14. 14. Study Maintenance Costs• Continuing regulatory reporting• Maintaining Investigator binders/files• Staff training needs• Research team meetings• Study communications• Sponsor monitoring visits• Adverse Events reporting
  15. 15. Data Collection & Subject Maintenance Costs• Case report forms completion• Scheduling for visits, tests/scans• IDS study article dispensing/ accounting• Subject payments• Telephone contacts• Data query resolution
  16. 16. UM Resources Utilization• GCRC Outpatient Clinic• M-Labs vs. Central Laboratory• Photocopying• Freezers, dry ice, special equipment• Committee review of devices, radioisotopes, or gene-transfer material
  17. 17. Consider “Hidden” Study CostsDelayed startInformed consent processIncreased salaries & operating costs over timeTravel to offsite clinics
  18. 18. More “Hidden” Study CostsUnscheduled visitsOverhead costs for “a la carte” or one-time proceduresTracking study fundsAudits
  19. 19. Consider Closing CostsDon’t forget – Closing costs occur AFTER subjects complete study and BEFORE contract ends – Query resolution to close database – Sponsor’s close-out visit – Pharmacy close-out – IRB termination – Long-term storage of research records
  20. 20. Potentially Unallowable Costs:• Dependent on – State law – Michigan contracting policy• Includes: – Finder’s fees/Referral fees – Enrollment incentives – Paperwork completion incentives
  21. 21. Now What?You’ve cost out your entire protocolYou’ve identified every dollar you will need to do the studyYou’ve reread the protocolYou’re ready to negotiatea budget!
  22. 22. Revisit: Clinical Trial Budget Categories Fixed Competitive Site Budget Budget Bid Proposal Offered by Site submits Site submits to sponsor or proposal to sponsor without CRO sponsor in site pre-determined selection process budget limitsFixed Costs v. Subject Dependent Costs
  23. 23. Build a Payment Schedule & Budget You Can “Live With”• The payment schedule must be appropriate for recovering costs as they are incurred• Negotiate non-recurring costs as “fixed” and not patient based• Be aware of milestones set for release of study funds…
  24. 24. Build a Payment Schedule & Budget You Can “Live With”• Recover cost of screen failures and study drop-outs• Include provisions for sponsor support for extra procedures or variable cost items
  25. 25. For Competitive Bids:Consider asking for Total Costs in your payment schedule – Instead of $500 for a routine visit, ask $625 – Don’t break out the indirect costs at the bottom of the schedule
  26. 26. For Sponsor or CRO Proposed Budgets: REMEMBER:If the contract is drafted by sponsor, it is probably to the sponsor’s benefit!–You CAN negotiate different payment milestones–You CAN ask for additional recovery if what theyare offering doesn’t cover your expense
  27. 27. If you think you and sponsorhave a budget you agree on: Ask: Is the research effort and scientific contribution worth the budget cost vs. recovery from sponsor?
  28. 28. This May Not be the Final Budget!Understand that this may not be “cased closed” and final – Needs agreement by your department, school, and universityInstitutional agreement is only given by DRDA, not by any faculty member…
  29. 29. Routing Information• What? – PAF, study budget, internal budget, draft contract, and protocol• When? – After the study budget is agreed to by both you and the sponsor – Before contract terms are fully negotiated• Where? – Through your division, department, Medical School, and DRDA
  30. 30. Routing Hints• The PAF and internal budget should match the bottom line of the payment schedule (“Contract Worth”)• If faculty have effort, please quantify on the internal budget• If the IND/IDE is open & active, indicate status under the Notes section of the PAF• Estimate a probable maximum number of patients for Per Patient budgets so that you do not have to route for additional patients later
  31. 31. Words to the Wise: Re-Negotiation is an Option• Even if you are mid-study!• Increased mid-study workload may justify additional sponsor funding. – Requires routing another PAF for additional dollars, but worth the recovery• If sponsor extends the study period, contact DRDA directly for a No- Cost Time Extension (NCTX)
  32. 32. Words to the Wise: Know What’s Going On with Study Funds!• Track $$ received from sponsor and study expenditures.• The PI is responsible for study deficits• Industry studies are not always “money-makers.” X
  33. 33. Contact Information: University of Michigan Medical School Administration The Center for Advancement of Clinical Research http://www.umich.edu/cacr Medical School Grants Officehttp://www.med.umich.edu/medschool/grants

×